Beilhack, G.; Monteforte, R.; Frommlet, F.; Reindl-Schwaighofer, R.; Strassl, R.; Vychytil, A.
Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave. Vaccines 2023, 11, 1121.
https://doi.org/10.3390/vaccines11061121
AMA Style
Beilhack G, Monteforte R, Frommlet F, Reindl-Schwaighofer R, Strassl R, Vychytil A.
Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave. Vaccines. 2023; 11(6):1121.
https://doi.org/10.3390/vaccines11061121
Chicago/Turabian Style
Beilhack, Georg, Rossella Monteforte, Florian Frommlet, Roman Reindl-Schwaighofer, Robert Strassl, and Andreas Vychytil.
2023. "Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave" Vaccines 11, no. 6: 1121.
https://doi.org/10.3390/vaccines11061121
APA Style
Beilhack, G., Monteforte, R., Frommlet, F., Reindl-Schwaighofer, R., Strassl, R., & Vychytil, A.
(2023). Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave. Vaccines, 11(6), 1121.
https://doi.org/10.3390/vaccines11061121